New algorithm for quantifying vascular changes in dynamic contrast-enhanced MRI independent of absolute T1 values.
about
Imaging biomarker roadmap for cancer studiesDCE-MRI and IVIM-MRI of rabbit Vx2 tumors treated with MR-HIFU-induced mild hyperthermia.Feasibility of using limited-population-based average R10 for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced magnetic resonance imaging data.Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.Dynamic contrast-enhanced magnetic resonance imaging of sunitinib-induced vascular changes to schedule chemotherapy in renal cell carcinoma xenograft tumors.Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer.Dynamic contrast-enhanced MRI assessment of hyperemic fractional microvascular blood plasma volume in peripheral arterial disease: initial findings.Diagnosis of brain tumors using dynamic contrast-enhanced perfusion imaging with a short acquisition timeAntitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virusDynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcoma.Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibitionA clinically feasible method to estimate pharmacokinetic parameters in breast cancer.Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors.Imaging and quantification of metastatic melanoma cells in lymph nodes with a ferritin MR reporter in living mice.Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.Ischemia-reperfusion injury in rat skeletal muscle assessed with T2-weighted and dynamic contrast-enhanced MRI.The impact of reliable prebolus T 1 measurements or a fixed T 1 value in the assessment of glioma patients with dynamic contrast enhancing MRI.Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival.Dynamic contrast-enhanced magnetic resonance imaging parameters independent of baseline T10 values.T2*-correction in dynamic contrast-enhanced MRI from double-echo acquisitions.Comparison between the Prebolus T1 Measurement and the Fixed T1 Value in Dynamic Contrast-Enhanced MR Imaging for the Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Concurrent Radiation Therapy and TemozolomiGlioma Grading and Determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion.Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results.T1 in high-grade glioma and the influence of different measurement strategies on parameter estimations in DCE-MRI.Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.Glioma: Application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading.The effect of blood inflow and B(1)-field inhomogeneity on measurement of the arterial input function in axial 3D spoiled gradient echo dynamic contrast-enhanced MRI.Estimating B1+ in the breast at 7 T using a generic template.
P2860
Q30242020-097AE98F-CCA9-4B8C-9A2C-7B5CF396A2D5Q30388286-42FF3322-9E4A-4ACF-B665-A47FBAAEC5B7Q33417505-4EA718E3-409B-40F3-A14A-E95DB036E77CQ33904348-0A3A8EE2-A88F-43F2-AFBC-F0659EF2A0A4Q34111200-BFA61D34-3935-4B52-A707-B8E6AED07CCCQ34138733-845698F3-3DD5-4B63-A5D8-BB54094CDF22Q34291246-0E455D02-AB9D-4D00-890E-65D0C37FC281Q35175935-51FB9369-1963-4AD8-993B-C70D65CDB0DDQ35750059-98A54586-5410-40C5-88A3-6768B5E6273CQ35848410-D8C7EF36-F696-463F-B222-2EA42AE95A5BQ37279800-27AE5225-4911-4CEA-A6D8-AC9112557C6DQ37309502-526F86F6-C76F-46D8-B02D-6776A57B0081Q37328130-6EC05149-7BBA-40C8-AD98-EAFAC4A45349Q38468002-E8AA5624-3C9B-4759-A086-826AA444D5F2Q38847085-DDE802A6-1E83-47BD-9D2F-57A66D2AFDACQ39270245-EAF26A33-FB87-4670-8D50-4198D5E1F908Q40261840-6D0BB583-A75F-43A5-A20A-693AAC3BD38FQ40433973-9E7D5238-37AE-474C-B153-DFEB9F7BDA27Q41416115-A8ED24C7-2441-46A1-B5FE-E879E805FD11Q42585152-826F21A6-D669-4CE6-9A78-A40585D224CFQ45226683-366A2C4F-3A49-4F0C-8486-173528204BD1Q47406548-09F24EBA-F84A-45AF-BF94-69663792968CQ48167305-DD3C67D8-36F3-4881-A089-174C05305D06Q48327067-BC0F44BC-56A1-4561-8F2E-ECBB05A76E23Q48473104-D7E5004B-7100-456E-9CB1-8323974D4D47Q51079367-C9FB5D77-2B59-4C4F-9E09-5211281DFDEFQ51127089-7F52C4C3-6358-4D78-877B-ED74D94B214EQ51650425-6F47AD98-1256-480C-8F75-94B58269CD62Q55309798-B7AC45CD-06A1-4D82-B1EC-6946A318954E
P2860
New algorithm for quantifying vascular changes in dynamic contrast-enhanced MRI independent of absolute T1 values.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
New algorithm for quantifying ...... pendent of absolute T1 values.
@en
type
label
New algorithm for quantifying ...... pendent of absolute T1 values.
@en
prefLabel
New algorithm for quantifying ...... pendent of absolute T1 values.
@en
P2093
P356
P1476
New algorithm for quantifying ...... pendent of absolute T1 values.
@en
P2093
Areen Al-Bashir
Carlo Ciulla
Cristina L Filleti
E Mark Haacke
Jaladhar Neelavalli
Jing Jiang
Krithivasan Suryanarayanan
Rajesh Kanaparti
Ramtilak Gattu
P304
P356
10.1002/MRM.21358
P577
2007-09-01T00:00:00Z